IPO Premiums
IPO calendar
MLListed

Mahamaya Lifesciences Limited

Bookbuilding IPO · BSE

Price band
₹108 - ₹114
Lot size
1,200 shares
Issue amount
₹70.44 cr
Total subscription
1.71×
Current price₹181
Listing price ₹116
Watch live price ↗
Opens
11 Nov 2025
Closes
13 Nov 2025
Allotment
14 Nov 2025
Listing
18 Nov 2025

Offer at a glance

Issue overview

Issue size
61,78,800 shares
Face value
₹10 per share
Minimum investment
₹1,29,600
Fresh issue
₹60.75 cr
Offer for sale
₹6.16 cr
Registrar
Kfin Technologies Limited
Listing exchange
BSE
Maximum investment
₹1,36,800
Issue type
Bookbuilding IPO
Shares before issue
1,77,66,200
Shares after issue
2,34,05,000

Lot sizes

CategoryLotsSharesAmount
RETAIL22,400₹2,73,600
sHNI33,600₹4,10,400
bHNI89,600₹10,94,400

Share reservation

Anchor28.36%
QIB19.03%
HNI14.27%
RETAIL33.33%
Market Maker5.01%

Subscription & GMP

Subscription by category

Total subscribed1.71×

Reported 13 Nov 2025

QIB1.19×
NIB3.99×
RETAIL1.02×
HNIs(10L+)5.53×
HNIs(2-10L)0.9×

GMP history

00.514 Nov: ₹06 Nov: ₹010 Nov: ₹011 Nov: ₹012 Nov: ₹013 Nov: ₹014 Nov: ₹0
4 Nov₹014 Nov

Day-wise demand

11 Nov0.11×
12 Nov0.42×
13 Nov1.71×

Application-wise demand

CategoryReserved applicationsApplied applications
QIB09
NIB0146
RETAIL858878
HNIs(10L +)16383
HNIs (2-10L)8263

Subscription demand

Amounts in ₹ crore. HNI subcategories are included in the NII total.

CategoryOfferedDemand
QIBs13.4115.98
FIIs06.66
Others09.32
RETAIL23.4724.02
NIB10.0540.07
HNIs 2+3.353.01
HNIs 10+6.737.06

Financial performance

Company financials

In Crores · Reported periods may include interim results.

Revenue & profitIn Crores
0100200300Mar-23 · Revenue: 137.4Mar-23 · Profit after tax: 3.75Mar-23Mar-24 · Revenue: 162.83Mar-24 · Profit after tax: 5.22Mar-24Mar-25 · Revenue: 267.17Mar-25 · Profit after tax: 12.94Mar-25Jun-25 · Revenue: 84.04Jun-25 · Profit after tax: 4.1Jun-25
RevenueProfit after tax

Key performance indicators

MetricJun-25Mar-25Mar-24
EPS2.317.63.26
ROE7.9734.9423.67
ROCE7.323.1516.16
RONW000
PRE IPO(PE)015.650
POST IPO(PE)16.2500

Values and labels as reported in the issue data.

Peer comparison

CompanyP/E(X)CMP* (₹)Face value (₹)NAV/Share (₹)RONW(%)EPS (Basic) (₹)
Mahamaya Lifesciences Limited00027.8226.197.60
Nova Agritech Limited16.930023.7612.473.05
Bhagiradha Chemicals & Industries Ltd247.630052.612.031.14

Company information

Company profile

Incorporated in 2002, Mahamaya Lifesciences Limited is engaged in the manufacturing, registration, and export of high-quality crop protection products and bioproducts designed to enhance soil and crop health. The company specializes in pesticide formulations and supplies bulk products to leading Indian agrochemical players as well as multinational corporations (MNCs). Mahamaya imports global research-based molecules, registers them with the Central Insecticides Board, and markets both technical and value-added formulations. The company has invested significantly in global registrations and currently exports to markets such as the Dominican Republic, Egypt, Ethiopia, Jordan, UAE, and Turkey. Its portfolio spans bulk formulations, technical grade molecules, branded products, and export-focused formulations.

Strengths

  • Experienced Leadership: Managed by a skilled team with deep expertise in agrochemicals, R&D, exports, and regulatory affairs, driving strategic and operational efficiency.
  • Comprehensive Product Range: Diverse lineup of insecticides, herbicides, fungicides, and bioproducts across technical, branded, and export formats ensures wide market presence.
  • Robust R&D and Regulatory Strength: Strong capability in molecule discovery and registration with Indian and global authorities enhances innovation, compliance, and market expansion potential.

Risk factors

  • High Customer Dependence: The company’s revenue relies heavily on a limited number of clients, with the top 10 customers contributing 71.35%, 76.26%, 83.14%, and 71.12% of total sales for the quarter ended June 30, 2025, and fiscal years 2025, 2024, and 2023, respectively, reflecting a notable concentration risk.
  • Absence of Long-Term Agreements: The company operates without long-term contracts with customers or suppliers, exposing it to potential fluctuations in demand, pricing, and supply continuity.
  • Volatility in Raw Material Costs: As raw materials constitute a significant portion of total expenses, any increase in prices or disruption in availability could adversely affect profitability and operational stability.

Promoters

Mr. Krishnamurthy Ganesan

Mrs. Lalitha Krishnamurthy

Mr. Prashant Krishnamurthy

Registrar & documents

Lead manager

Oneview Corporate Advisors Private Limited

Registered office

Unit No: DPT – 033, Ground Floor, Plot No: 79 – 80, DLF Prime Tower, Block, Okhla, Phase – 1 Delhi, New Delhi, 110020

+91-1146561474

[email protected]Company website ↗

Frequently Asked Questions

What is Mahamaya Lifesciences IPO GMP today?

Currently, Mahamaya Lifesciences IPO Grey Market Premium (GMP) is trading around ₹0 or awaiting active buyer-seller quotes in the grey market. The issue price is set at ₹114. Track daily updates on IPO Premiums as bidding numbers unfold.

What is the lot size and minimum investment for Mahamaya Lifesciences IPO?

The minimum bid lot size for Mahamaya Lifesciences IPO is 1,200 shares. At the cut-off price of ₹114 per share, retail investors need a minimum application amount of ₹1,36,800 per lot. Retail applicants can apply for a maximum of 1 lots (up to ₹2,00,000).

When will Mahamaya Lifesciences IPO allotment status be announced?

The allotment status for Mahamaya Lifesciences IPO is scheduled to be finalized on 14 Nov 2025. If you applied for the IPO, you can verify whether shares have been allocated to your Demat account through Kfin Technologies Limited's official portal or via BSE/NSE allotment portals.

How can I check Mahamaya Lifesciences IPO allotment status online by PAN?

To check Mahamaya Lifesciences IPO allotment status: 1) Visit the registrar portal (Kfin Technologies Limited) or the BSE IPO allotment page. 2) Select 'Mahamaya Lifesciences Limited' from the company dropdown. 3) Choose 'PAN' as your identification mode and enter your 10-digit Permanent Account Number. 4) Click 'Search' to view your allotted share quantity and application status.

Explore More IPO Analysis & Live Tools

Compare the price band and required investment with company financials and official offer documents. Grey market premium (GMP) figures are indicative market estimates collected from primary market brokers and do not establish the official listing price.

Regulatory Disclaimer: Grey Market Premium (GMP) is an unofficial, unregulated indicator of market sentiment and does not represent a stock exchange transaction, guarantee, or investment advice. IPO Premiums is an informational and research portal and is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before applying for any IPO.